Lungekreft i JCO, NEJM, The Lancet
- Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography
- Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer?
- High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538
- Lung cancer screening
- Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2
- Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2
- Clonal Hematopoiesis and Risk of Incident Lung Cancer
- Exploring the Next Frontier in Non-Small-Cell Lung Cancer With High MET and Mutated Epidermal Growth Factor Receptor
- Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study
- Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
Norske lungekreftpublikasjoner
- Accuracy of instrument tip position using fiber optic shape sensing for navigated bronchoscopy
- Accuracy of instrument tip position using fiber optic shape sensing for navigated bronchoscopy
- Accuracy of instrument tip position using fiber optic shape sensing for navigated bronchoscopy
- Accuracy of instrument tip position using fiber optic shape sensing for navigated bronchoscopy
- Accuracy of instrument tip position using fiber optic shape sensing for navigated bronchoscopy
- Accuracy of instrument tip position using fiber optic shape sensing for navigated bronchoscopy
- Nanopore sequencing of 1000 Genomes Project samples to build a comprehensive catalog of human genetic variation
- Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma
- UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
- Distribution and characteristics of malignant tumours by lung lobe